<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00988455</url>
  </required_header>
  <id_info>
    <org_study_id>pdt bcc 2</org_study_id>
    <secondary_id>zthr</secondary_id>
    <nct_id>NCT00988455</nct_id>
  </id_info>
  <brief_title>Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma With 6 Months Follow-up</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shahid Beheshti University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shahid Beheshti University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of photodynamic therapy (PDT)in&#xD;
      treatment of Basal cell carcinoma (BCC) and recurrence rate after 6 months.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background and Aim:&#xD;
&#xD;
      Basal cell carcinoma (BCC) is the most common skin cancer .Photodynamic therapy _as a novel ,&#xD;
      non-invasive therapeutic approach _may be considered a valuable strategy. This study was&#xD;
      designed with the aim of the evaluation of efficacy of PDT in treatment of BCC and recurrence&#xD;
      rate after 6 months .&#xD;
&#xD;
      Materials and Methods:&#xD;
&#xD;
      This was a clinical trial which was done on 28 BCCs. Patients were treated with ALA-PDT&#xD;
      monthly for 1-6 sessions and evaluated for clinical response,cosmetic results,recurrence rate&#xD;
      and probable side effects.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>response rate at the end of therapy protocol (regarding tumor diameter and/or pathologic examination)</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>recurrence rate(regarding clinical and/or pathological examination) after 6 months of follow up</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Basal Cell Carcinoma</condition>
  <arm_group>
    <arm_group_label>BCC, ALA-PDT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with histologically proven basal cell carcinoma who were candidates for treatment with ALA-PDT</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>photodynamic therapy</intervention_name>
    <description>5-ALA cream 20% topical administration + photodynamic therapy (red light) 120 j/cm2</description>
    <arm_group_label>BCC, ALA-PDT</arm_group_label>
    <other_name>PDT 1200L Waldman Medizintechnik, Villengen; Schwenningen, Germany</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Histologically proven BCCs&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Rodent ulcer&#xD;
&#xD;
          -  Morphea type&#xD;
&#xD;
          -  ANA +&#xD;
&#xD;
          -  History of photosensitivity or photodermatosis or ingestion of phototoxic drugs during&#xD;
             last month&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Breast feeding&#xD;
&#xD;
          -  Age&lt; 18&#xD;
&#xD;
          -  History of another therapeutic intervention for bcc during last 6 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>zohreh Tehranchi-nia, assist.prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>skin research center</affiliation>
  </overall_official>
  <verification_date>October 2009</verification_date>
  <study_first_submitted>September 29, 2009</study_first_submitted>
  <study_first_submitted_qc>October 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2009</study_first_posted>
  <last_update_submitted>October 1, 2009</last_update_submitted>
  <last_update_submitted_qc>October 1, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 2, 2009</last_update_posted>
  <responsible_party>
    <name_title>Zohreh Tehranchi-nia</name_title>
    <organization>assistant professor of dermatology</organization>
  </responsible_party>
  <keyword>basal cell carcinoma</keyword>
  <keyword>photodynamic therapy</keyword>
  <keyword>photo chemotherapy</keyword>
  <keyword>basal cell epithelioma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Basal Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

